2022 Revenues ($USD) : $6,821,600,000
2022 R&D spend : $435,900,000
2022 Number of Employees : 16,800
Fiscal Year End : 12/31/2021
Company CEO : Bryan Hanson, chair, president and CEO

Zimmer Biomet has had a great deal of news over the past year. It spun off its dental and spine business as ZimVie in March. ZB has also introduced new ortho surgical offerings based on AI and mixed reality. They were also the first out of the gate with smart knee implants.

“We believe our focus on innovation and the transformation of our business continues to position us well for long-term growth and continued delivery for our shareholders,” CEO Bryan Hanson said during the company’s Q2 earnings call in August. – CN